On December 18th, 2017, the Marijuana Enforcement Division (MED) issued industry bulletin 17-09 in regards to new testing requirements that will go into effect January 1st, 2018.

“…Medical and Retail Marijuana Rules effective January 1, 2018, reflect several changes to testing requirements in the Medical (M) and Retail (R) 700 and 1500 Series rules. This Industry‐wide Bulletin highlights several of those changes; however, Licensees should review all changes to these rules in advance of January 1, 2018”

Read the bulletin here:

BULLETIN 17-09

What is changing?

SAMPLE COLLECTION PROTOCOLS

Licensees will be required to follow new sample collection protocols. Those protocols will be published in the Colorado Department of Public Health and Environment’s (CDPHE) Reference Library by Wednesday, December 27, 2017.

SAMPLE SIZE REQUIREMENTS

Under Rules M and R 1504 (B)(1‐4), Test Batches must meet minimum size or amount requirements based on the category of marijuana and size of the Harvest or Production Batch.

  • Test Batches may be submitted for multiple required tests. For example, you may submit a potency and microbial test using one METRC tag.

  • Multiple Harvest or Production Batches may not be combined into a single Test Batch.

ONGOING TESTING

Amendments to Rules M and R 1501 and 1503 increase the frequency of required testing for Licensees that have achieved process validation.

  • Contaminant Testing Once Every 30 Days.

    • Potency Testing Once Per Quarter.

    RESIDUAL SOLVENT ACCEPTABLE LIMITS

    Amendments to Rules M and R 712 (E)(3) change the acceptable limits of residual solvents that may be present in a Solvent‐Based Concentrate.

    • New Limits Apply February 1, 2018.

      • If the Retail Marijuana Products Manufacturing Facility has achieved Process Validation for residual solvents, the first three Production Batches of Solvent‐Based Concentrates must be submitted for residual solvent contaminant testing.

        • If the new acceptable limits for residual solvents results in a material change to the Retail Marijuana Products Manufacturing Facility’s process, re-validation of process will be required pursuant to Rule R 1501 (F)(1).

        MANDATORY MEDICAL MICRO AND RESIDUAL SOLVENT TESTING 

        • Beginning February 1, 2018.

          • Mandatory testing of Medical Marijuana, Medical Marijuana Concentrate, and Medical Marijuana‐ Infused Products applies to all Harvest and/or Production Batches created on or after February 1, 2018.

            • Harvest and/or Production Batches created prior to February 1, 2018, are not subject to microbial contaminant and residual solvent contaminant testing requirements

            PESTICIDE AND MYCOTOXIN TESTING 

            Requirements for Pesticide testing and mycotoxin contaminant testing in the Medical and Retail Marijuana Rules will not be implemented until proficiency testing is established and Medical and Retail Marijuana Testing Facilities are certified at sufficient capacity.

            Contact us

            Agricor Laboratories will give you the peace of mind that you’re business is getting the right analytical answer. Our methods and processes have been thoroughly validated to ensure accuracy and repeatability in the data we provide. We’re ISO 17025 certified and follow current Good Manufacturing Practices and Good Laboratory Practices. To learn more, feel free to give us a call at (720) 460-3489 or contact us at support@agricorlabs.com.